Several possible studies
Story checked
AHA: Cannabis use linked to increased odds of atherosclerotic cardiovascular disease (opens in a new tab)
medicalxpress.com · 2026-11-05
Short answer
Several possible studiesStudy not confirmed.
Several potential source studies were identified, but no single match could be confirmed. The article's claims remain unverified.
These papers were considered as possible sources, but none could be confirmed as the study behind this story.
Share this check
Help improve NewsLink
Tell us what worked or what needs attention in this check.
The story
AHA: Cannabis use linked to increased odds of atherosclerotic cardiovascular disease
medicalxpress.com · 2026-11-05
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Multiple potential source studies identified.
Several studies match details in the article, but none could be confirmed as its source. The claims have not been assessed against a source study.
View article claimsSearch result
Several studies could fit.
Several studies match details in the article, but none could be confirmed as its source. The claims have not been assessed against a source study.
Evidence layer
Claim by claim
The article's claims are listed below. Without a confirmed source study, they have not been assessed as supported or unsupported.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 9Not checkedCannabis use is associated with increased odds of atherosclerotic cardiovascular disease (ASCVD) in specific subgroups, including never-smokers, women and young adults without traditional risk factors.View evidenceHide evidence
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 2 of 9Not checkedThe finding was presented at the American Heart Association Scientific Sessions 2026, held Nov. 6 to 9 in Chicago.View evidenceHide evidence
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 3 of 9Not checkedAabha Divya and colleagues examined cannabis use frequency and prevalent ASCVD in a nationally representative sample using pooled 2020 to 2024 Behavioral Risk Factor Surveillance System data.View evidenceHide evidence
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 4 of 9Not checkedAmong 577,057 adults, any cannabis use increased 52% from 10.5% in 2020 to 16.0% in 2024.View evidenceHide evidence
As stated52% relative increase; 10.5% to 16.0%
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 5 of 9Not checkedIn the primary adjusted analysis, cannabis use was directionally associated with higher odds of ASCVD across frequency categories, although the estimates did not reach statistical significance.View evidenceHide evidence
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 6 of 9Not checkedThere was a significant cannabis-by-sex interaction, with stronger associations seen among women; moderate cannabis use was significantly associated with ASCVD among women.View evidenceHide evidence
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 7 of 9Not checkedLow-frequency cannabis use was independently associated with ASCVD in never-smokers, and heavy cannabis use was significantly associated with ASCVD among adults aged 18 to 44 years without diabetes, hypertension or obesity.View evidenceHide evidence
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 8 of 9Not checkedStates with recreational legalization exhibited stronger associations.View evidenceHide evidence
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 9 of 9Not checkedThe researchers said the link was not straightforward and expected cardiovascular risk to rise gradually with more cannabis use, but that was not what they observed.View evidenceHide evidence
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Method layer
Study not confirmed.
The search results are available for you to inspect. Without a confirmed source study, they cannot establish whether the story’s claims are supported or contradicted.
Search results
Candidate papers, not confirmed sources.
PubMed, Crossref, Europe PMC · 15 candidate papers
Synthetic Cannabinoid (Mojo)-Induced ST-Segment Elevation Myocardial Infarction: A Case Report.
Cureus · 2025 · PubMed
Composite dietary antioxidant index is inversely and nonlinearly associated with cardiovascular disease, atherosclerotic cardiovascular disease, and cardiovascular mortality in people with dyslipidemia: evidence from NHANES 2001–2018
Frontiers in Nutrition · 2025 · Crossref
Acute Coronary Syndrome and Recreational Drug Use: A Comprehensive Review.
2026 · Europe PMC
Cannabis use and atherosclerotic cardiovascular disease outcomes: A meta-analysis of multinational cohort data.
Disease-a-month : DM · 2025 · PubMed
Inflammation - The Connecting Bridge between Periodontitis (Gum Disease) and Atherosclerotic Cardiovascular Disease (ACVD)
Crossref